Brain stimulation in obesity

  title={Brain stimulation in obesity},
  author={Carl H. G{\"o}bel and Volker M. Tronnier and T. M{\"u}nte},
  journal={International Journal of Obesity},
Obesity is taking up epidemic proportions worldwide with significant impacts on the health of both the affected individual and on society as a whole. Treatment approaches consist of behavioural and pharmacological approaches, however, these are often found to be ineffective. In severe obesity, bariatric surgery is frequently performed. Unfortunately, 40% of patients show substantial weight gain over the long term or display the associated metabolic syndrome, making the development of novel… 

The Other Obesity Epidemic—Of Drugs and Bugs

The role of gut bacterial community in psychotropic drugs metabolism and dysbiosis is reviewed, potential biomarkers reflecting the status of Bacteroidetes phylum are discussed, and a closer look at nutritional interventions, fecal microbiota transplantation, and transcranial magnetic stimulation, strategies that may lower obesity rates in chronic psychiatric patients are taken.

Alternative Strategies for Managing Insomnia: The Case of Physical Exercise and Transcranial Direct Current Stimulation. A Narrative Review

Current data suggest that these two strategies efficiently manage insomnia, and in turn opens new approaches to develop therapeutical tools to diminish this pathology, although additional research is required to understand the neurobiological mechanism of action of physical exercise and tDCS in insomnia control.

Five weeks of intermittent transcutaneous vagus nerve stimulation shape neural networks: a machine learning approach

This study shows tVNS’ post-stimulation effects on fALFF in the salience rs-network and finds a classification accuracy (CA) of 79 % in a subset of four brainstem regions suggesting that tV NS leads to lasting changes in brain networks.

Effect of Short-Term Transcutaneous Vagus Nerve Stimulation (tVNS) on Brain Processing of Food Cues: An Electrophysiological Study

This study demonstrates tVNS’ impact on visual processing by demonstrating a negative relationship between P2 amplitude and food intake for the sham stimulation and analyzed the event-related potentials P1, P2, N2, and LPP.

Anatomo-Physiologic Basis for Auricular Stimulation.

Accumulating evidence suggests that VNS and TNS share multiple levels and mechanisms of action in the central nervous system, however, the sites and neurobiologic mechanisms by which they produce their therapeutic effects are not clear yet.

Bariatric surgery in obese patients reduced resting connectivity of brain regions involved with self‐referential processing

Bariatric surgery significantly decreased FCD in regions involved in self‐referential processing (VMPFC, D MPFC, dACC, and precuneus), and interoception (insula), and changes in VMPFC/precuneus were associated with reduction in BMI suggesting a role in improving control of eating behaviors following surgery.

Neuroendocrinological mechanisms underlying impulsive and compulsive behaviors in obesity: a narrative review of fMRI studies

An overview of neuroimaging studies exploring impulsivity and compulsivity factors as they relate to weight status and research on the associations between brain response with neuroendocrine factors, such as insulin, peptide YY, leptin, ghrelin and glucagon-like peptide 1, will be reviewed.

Repetitive Transcranial Magnetic Stimulation

This chapter reviews the applications of noninvasive neuromodulation repetitive transcranial magnetic stimulation (rTMS) in psychological and behavioral disorders associated with obesity.

The dynamic nature of food reward processing in the brain

It is proposed that the neural response to food stimuli is dynamic, and in synchrony with the current motivational and cognitive state of an individual, and why multivariate approaches to functional MRI (fMRI) data-analysis may carry the field forward.



Deep brain stimulation in the treatment of obesity.

It is concluded that deep brain stimulation should be strongly considered as a promising therapeutic option for patients suffering from refractory obesity.

Hypothalamic Deep Brain Stimulation Reduces Weight Gain in an Obesity-Animal Model

The efficacy and behavioral safety of a low frequency VMH-DBS application as a potential clinical strategy for modulation of body weight are demonstrated in a porcine obesity model.

Deep brain stimulation in addiction: a review of potential brain targets

The analysis of the literature suggests that the NAc is currently the most promising DBS target area for patients with treatment-refractory addiction, and the mPFC is another promising target, but needs further exploration to establish its suitability for clinical purposes.

Deep brain stimulation for treatment of obesity in rats.

Bilateral electrical stimulatory inhibition of the LH is effective in causing significant and sustained weight loss in rats.

Brain Stimulation in Addiction

Overall, these studies indicate that brain stimulation has an acute effect on craving for drugs and alcohol, but few studies have investigated the effect of brain stimulation on actual drug and alcohol use or relapse.

Peripheral neural targets in obesity

This work discusses mechano‐ and chemosensory pathways from the gut involved in appetite suppression, and distinguishes between gastric and intestinal vagal afferent pathways in terms of their basic physiology and activation by enteroendocrine factors.

Deep Brain Stimulation Reveals a Dissociation of Consummatory and Motivated Behaviour in the Medial and Lateral Nucleus Accumbens Shell of the Rat

Data indicate that the intake of chow and the motivation to work for palatable food can independently be modulated by DBS of subregions of the NAcc shell, which provides important leads for the possible future application of DBS as a treatment for eating disorders such as anorexia nervosa.

Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism.

Deep brain stimulation of the LHA may be applied safely to humans with intractable obesity and early evidence for some weight loss under metabolically optimized settings provides the first "proof of principle" for this novel antiobesity strategy.

Pharmacotherapy for obesity

Important drug targets that are highlighted in this review include adipocyte-derived hormones, hypothalamic neuropeptides, and gastrointestinal hormones that have led to new opportunities for antiobesity drug development.